Table 2 Trial Procedures and outcomes
Intervention (n = 17) | Control (n = 17) | |
|---|---|---|
VAD delivered VM, n | 17 | 0 |
Control delivered VM, n | 0 | 17 |
Mean number of VM attempts, n (range) | 2.3 (1–3) | 2.7 (1–3) |
Modified VM used, n | 14 | 13 |
Legible pre-VM ECG available, n (%) | 16 (94) | 15 (88) |
Legible post-VM ECG available, n (%) | 16 (94) | 16 (94) |
Cardioversion, n (%, 95%CI)* | 4 (24, 10 to 47) | 0 (0, 0 to 18) |
Not conveyed to hospital, n (%, 95%CI) | 2 (12, 3 to 34) | 0 (0, 0 to 18) |
Total mean (median, range) ambulance episode duration (min) | 62 (54, 27 to 117) | 58 (61, 29 to 102) |
Consent for phone follow-up, n | 16 | 13 |
Phone follow up completed, n | 12 | 9 |
Eligible presenting rhythm+, n | 14 | 13 |
ECG Evidence of cardioversion on post-VM ECG in eligible participants+, n (%) | 6 (43%) | 3 (23%) |